Hyalinizing trabecular tumour (HTT) is a rare thyroid neoplasm of follicular cell origin characterised by a trabecular growth pattern and prominent intratrabecular and intertrabecular hyalinisation. These peculiar histological features allow the prompt recognition of this neoplasm in surgical specimens. However, cytological diagnosis of HTT remains elusive and misleading because of overlapping characteristics with other thyroid tumours, particularly papillary thyroid carcinoma (PTC), medullary thyroid carcinoma (MTC) and the newly described noninvasive follicular thyroid neoplasm with papillary-like nuclear features (NIFTP). Nevertheless, the proper recognition of this neoplasm on preoperative cytological preparations is important to avoid unnecessary overtreatment of this indolent lesion. A thorough review of the literature has revealed that the correct diagnosis of HTT in cytological smears is achieved in only 8% of cases. In a further 6% of cases, diagnostic doubt has been indicated. Sixty percent of published cases of HTT have been misdiagnosed as suggestive, suspicious or positive for PTC. These findings underline the difficulties of a cytological-based diagnosis of such entity. In this article we review the cytomorphological features of HTT and their correlation to histological features to provide the reader with the tools to improve diagnostic performance in the identification of HTT on preoperative cytology.
INTRODUCTION
Hyalinizing trabecular tumour (HTT) is a distinct but rare thyroid neoplasm of follicular cell origin characterised by a trabecular growth pattern and prominent intratrabecular and intertrabecular hyalinisation. It usually occurs between the fourth and seventh decade of life and shows a marked predilection for women. 1 By and large, the clinical behaviour of HTT is benign and should therefore be treated conservatively, although it is worth noting that rare cases of invasive hyalinizing trabecular carcinomas have been reported in earlier literature. [2] [3] [4] Although the peculiar histological features of this neoplasm allow prompt recognition in surgical specimens, cytological diagnosis of HTT remains elusive and misleading because of overlapping characteristics with other malignant thyroid tumours, including papillary thyroid carcinoma (PTC) and medullary thyroid carcinoma (MTC). For this reason, HTT recognition in fine-needle aspiration (FNA) preparations is important to avoid unnecessarily aggressive treatment of such a benign neoplasm. 5 Furthermore, it is difficult to distinguish between HTT and the recently described 'noninvasive follicular thyroid neoplasm with papillarylike nuclear features (NIFTP)' in cytological preparations, mainly due to the fact that the cytological diagnostic criteria for both entities have not been well established yet. 6 7 The purpose of our review is to highlight the cytological and immunocytochemical features of HTT to help the practitioner cytopathologist with the difficult diagnosis of HTT, which represents the starting point for a correct therapeutic approach.
HISTORICAL PERSPECTIVE
The first two reports of HTT were described by Zipkin 8 and Masson 9 , who reported cases of HTT that they interpreted as carcinomas. Later, in 1982, Ward et al 10 described a similar case under the moniker 'hyaline cell tumor of the thyroid with massive accumulation of cytoplasmic microfilaments'. However, the concept of HTT as a benign lesion originates from Carney and coworkers who, in 1987, reported 11 cases of non-invasive and non-metastasising encapsulated thyroid tumours showing peculiar histological features, such as polygonal and elongated cells with a trabecular pattern of growth, associated with hyaline amyloid-like substance. They defined such lesions as hyalinizing trabecular adenomas (HTAs).
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Following Carney's description, most authors used the term HTA to define this neoplasm, and it was also adopted by the second edition of the WHO handbook on classification of thyroid tumours, where it was included in the chapter 'Other adenomas', together with salivary glandtype adenomas and adenolipomas. 12 Subsequently, since some authors described a few cases showing malignant behaviour (including metastases, vascular invasion or invasive growth into thyroid parenchyma) and RET/PTC rearrangements, the term HTT was considered a better moniker than HTA, and the lesion was classified as such in the third edition of the WHO classification. 1 
ULTRASONOGRAPHICAL FEATURES
In two out of three small published series investigating ultrasonographical features of HTT, the authors found that none of the patients showed any findings indicative of malignancy; 13 14 in the third one, only 29% of patients showed malignant ultrasound (US) findings. 15 Overall, authors described the vast majority of HTT as being solid tumours, hypoechogenic or markedly hypoechogenic.
CYTOPATHOLOGICAL FEATURES
Goellner and Carney 16 first reported the cytological characteristics of HTT, acknowledging that this lesion showed features suggestive of PTC and MTC. Cytological smears generally show cells that may be isolated, arranged in cohesive ( figure 1A, B) or loosely cohesive groups (figure 1C) or syncytial tissue fragments with a trabecular pattern ( figure 1D ). At times, neoplastic cells appear to radiate from central cores of acellular hyaline material or form follicle-like structures around it. Neoplastic cells are polygonal to spindle shaped, containing a pale to dense cytoplasm that is often difficult to visualise, and oval to elliptic nuclei containing evenly distributed chromatin and micronucleoli. Intranuclear pseudoinclusions and nuclear grooving ( figure 1B and D) are frequently observed. The yellow cytoplasmic bodies observed by histology may also be seen in cytological samples. 17 The presence of nuclear grooving, intranuclear pseudoinclusions and psammoma bodies may easily result in the diagnosis of PTC; indeed, the vast majority of published FNA cases were diagnosed on preoperative cytology as suggestive, suspicious or positive for PTC. 16 18-21 The hyaline material may be misinterpreted as amyloid, therefore suggesting a diagnosis of MTC, or even overlooked as colloid and not taken into account at all for diagnostic purposes. However, MTC aspirates show loosely cohesive groups with a dispersed pattern without any specific architectural configuration or isolated cells, whose nuclei are eccentric, pleomorphic, containing 'salt and pepper' chromatin and no nucleoli. Nuclear grooving and psammoma bodies are not observed in MTC. The strange combination of features of both PTC and MTC, as well as the fact that these features do not completely fit the criteria for either entity, is the most useful clue for recognising HTT by cytology. 16 Immunocytochemical staining can help in distinguishing these entities.
The difficulty of a cytological diagnosis of HTT is underlined by the fact that 60% of published cases of HTT in which a cytological diagnosis was included were misdiagnosed as suggestive, suspicious or positive for PTC (table 1) : among them, 41% were diagnosed as positive for PTC; 48% as suspicious for PTC; 6% as suggestive of PTC; 2% as consistent with PTC; 2% was diagnosed as follicular variant (FV)-PTC and 1% as a 'trabecular epithelial tumour in keeping with PTC'. Of the remaining 40% of cases, 6% were reported as PTC versus HTT; 10% as follicular neoplasms (FNs); 1% as MTC; 10% as atypia of undetermined significance (AUS); and, finally, only 8% of cases were correctly identified as HTT by FNA (figure 2). 16-26 28-33 Although architectural features are diminished in cytological samples, they are not absent, and must be taken into account and correctly interpreted when making a diagnosis. When considering the cytomorphological features of HTT, the absence of papillary structures and denuded fibrovascular stalks and the presence of elongated epithelial cells associated with acellular hyaline stroma are all significant clues. Moreover, cell blocks from residual material or needle rinse fluid can provide additional information and material for ancillary studies, that is, immunocytochemistry.
Furthermore, in challenging cases, cytomorphological findings can be integrated with US features to better refine the cytological diagnosis: in cases with discordant cytologicalultrasonographical findings, a note can be added to the diagnosis suggesting that when benign US features are present, HTT must be considered in the differential diagnosis of samples suspicious for malignancy (PTC). 
HISTOPATHOLOGICAL FEATURES
Grossly, HTT is usually a single, solid, well circumscribed or encapsulated lesion that presents a homogeneous and delicately lobulated yellow-tan cut surface, measuring 2.5 cm or less in diameter ( figure 3A ). 1 Microscopically, the main distinctive features are a diffuse trabecular-alveolar growth pattern and a prominent hyalinised intratrabecular stroma that closely resembles amyloid, although it is negative for amyloid stain ( figure 3B ). Neoplastic cells are medium to large sized, polygonal or fusiform, with a finely granular amphophilic, acidophilic or clear cytoplasm and nuclei showing prominent grooves and intranuclear pseudoinclusions (figure 3C). They are arranged in trabeculae supported by a delicate fibrovascular stroma. 1 In some cases, the spindle cell component may be so important as to suggest MTC ( figure 3B,  inset) ; however, immunostaining for calcitonin, CEA, and thyroglobulin helps in the differential diagnosis. The so-called 'yellow bodies', round paranuclear cytoplasmic pseudoinclusions with a light yellow tinge, slightly refractile and surrounded by a clear halo, are a peculiar feature of this neoplasm. 34 Colloid is scant or absent and calcifications/psammoma bodies may be observed. 1 In places, cells may be arranged in compact clusters closely resembling the 'Zellballen' of paraganglioma, hence the alternative name of paraganglioma-like adenoma sometimes encountered in the literature. 35 The hyaline material is closely associated with the trabeculae of HTT, is PAS positive and appears to be directly produced by neoplastic cells. It must be distinguished from the perivascular stromal hyalinisation that is characteristic of other thyroid tumours and which results from degenerative changes within the lesion. 1 35 Ultrastructurally, the main features of HTT are the accumulation of intermediate filaments in the cytoplasm of the tumour cells and the abundance of extracellular basal membrane material that suggest a deregulation of secretory patterns. [36] [37] [38] The yellow cytoplasmic inclusion bodies observed on H&E-stained sections, using electron microscopy are giant secondary lysosomes of multivesicular body subtypes. 34 
IMMUNOCYTOCHEMISTRY AND IMMUNOHISTOCHEMISTRY
HTT shows a distinctive cell membrane and cytoplasmic positivity for Ki-67 (using clone MIB-1) when the reaction is performed at room temperature. The cross reactivity of the monoclonal MIB-1 antibody with an epitope expressed at the cell membrane level seems to represent the putative mechanism of such findings. 39 Positive immunoreactivity with MIB-1 in cytoplasmic and membranous patterns has been described in cytological specimens as well, and it has been suggested as a useful test when applied to aspirates in which HTT is suspected, but whose cytological features do not permit a definitive diagnosis. 27 40 Therefore, immunocytochemistry can support the cytopathologist in diagnosing HTT in suspicious cases ( figure 3D, E) . Although most authors propose immunohistochemical staining for MIB-1 as a useful diagnostic tool, others have recommended that the results of this test need to be carefully interpreted, as its specificity is not proven. 39 41-43 It is worth noting that such a staining pattern is obtained only with the MIB-1 clone and not with other Ki-67 clones, and only when the procedure is carried out at room temperature. 39 If this peculiarity is not taken into account and staining with the MIB-1 clone is carried out at 37°C, a low-grade nuclear positivity will ensue and will lead to the wrong diagnosis.
In keeping with their presumed follicular cell origin, most tumour cells are positive for thyroglobulin, thyroid transcription factor (TTF)-1 and negative for calcitonin (table 2) . 1 Studies have shown discrepant results of cytokeratin (CK) profiling, with variable degrees of positivity for CK 7, 8, 18 and 19. [44] [45] [46] The staining for galectin-3, a β-galactosidase-binding lecithin used to differentiate benign and malignant follicular tumours, has been reported to be strong in 40% and weak or negative in 60% of HTTs. 47 Neuroendocrine differentiation, demonstrated by positivity for neuroendocrine markers such as chromogranin A and neuron-specific enolase, has been reported and proposed to account for the resemblance of an HTT growth pattern to paraganglioma and MTC. 36 48 49 
MOLECULAR BIOLOGY
Original detection of RET/PTC1 rearrangements in a percentage of cases similar to that described in PTC seemed to support the relationship between HTT and PTC that had also been suggested by some authors on the basis of morphological and cytological features. [50] [51] [52] In the study by Papotti et al 50 , 4 of the 14 (28.6%) HTT investigated, using reverse transcription PCR (RT-PCR) and Southern blot analysis, harboured RET/PTC1 rearrangements; Figure 3 Histological features of hyalinizing trabecular tumour (HTT). Low-power magnification shows an encapsulated lesion (A, H&E scanned slide) with the typical trabecular architecture and intratrabecular hyalinisation (B, H&E×100). Rare spindle cell variants of HTT exist, and may create diagnostic confusion with the spindle cell variant of medullary thyroid carcinoma (MTC) (B, inset, H&E×200). High-power magnification demonstrates intranuclear pseudoinclusions (arrow) and nuclear grooving (arrowhead) (C, H&E×400). Immunohistochemical staining with Ki-67 antibody (Mib-1 clone) at room temperature results in the characteristic peripheral cytoplasmic and membranous staining (D, ×200); when the reaction is performed at 37°C, no membrane localisation is observed (E, ×200). Table 2 Immunocytochemical staining in the differential diagnosis of hyalinizing trabecular tumour on fine-needle aspiration
+ (membranous) 100% expression at room temperature incubation; + (nuclear) low expression at 37°C incubation + (nuclear), usually low expression + (nuclear), variable expression CEA, carcinoembryonic antigen; HTT, hyalinizing trabecular tumour; MTC, medullary thyroid carcinoma; PTC, papillary thyroid carcinoma; TTF-1, thyroid transcription factor-1.
of five microRNAs known to be upregulated in PTC was retrospectively analysed in HTT and found to be different. 53 To date, no Next-Generation Sequencing study is available for HTT, nor have molecular analyses been applied to cytological material yet.
DIFFERENTIAL DIAGNOSIS
A review of the literature shows that the correct preoperative cytological diagnosis of HTT has been achieved in only 8% of cases, and in another 6% a diagnostic doubt has been indicated, while in the majority of cases the cytological diagnosis of malignancy was not confirmed on the resected surgical specimens (table 1) . Although it is generally believed that HTT can be frequently misdiagnosed as either PTC or MTC (because of the prominent PTC-like nuclear features and the presence of amyloid-like hyaline material, respectively), only 1% of HTT has been diagnosed as MTC by preoperative cytology, compared with 60% which were diagnosed as PTC.
Another entity that may appear in the differential diagnosis of HTT is NIFTP: confusion may arise because both entities present overlapping nuclear features of PTC in FNA material and because criteria for unequivocally identifying these entities by cytology have not yet been defined.
Primary thyroid paraganglioma, although extremely rare, may enter into the differential diagnosis, as HTT may present compact clusters that can be misinterpreted as 'Zellballen' typically observed in paraganglioma.
MANAGEMENT
FNA is an essential procedure in the preoperative evaluation of thyroid nodules. Its main role is the triage of patients who actually require surgery, thus reducing the number of unnecessary thyroidectomies and possible complications thereof. 54 Although radiological and US features are often not provided to cytopathologists, they must be searched for and taken into account to plan appropriate patient management in a multidisciplinary tumour board. Recent literature suggests that HTT should be included in the differential diagnosis of solid tumours with benign US features but cytology suggestive of PTC. [13] [14] [15] As a cytological diagnosis of PTC entails an aggressive surgical treatment including complete thyroidectomy associated or not with central neck dissection, the correct distinction between HTT and PTC by FNA is important to guide proper management of patients and to avoid overtreatment because HTT can be treated by a simple lobectomy.
It is important to note that an accurate diagnosis of HTT (and of any other neoplastic lesion) by FNA crucially depends on the sample being representative and adequate in cellularity and appropriately processed and stained, in order to provide high-quality preparations for assessment. When these conditions are not met, repeat sampling with or without on-site assessment should be considered prior to surgical management. Intraoperative consultation after a suboptimal cytological assessment is not the method of choice in patient management.
However, frozen section evaluation may have a role in guiding the correct surgical decision intraoperatively when it is prompted by a result of FNA cytology suspicious for malignancy on a sample that is representative of the lesion and well processed: providing a trabecular pattern is identified, an initial lobectomy may be performed and total thyroidectomy may be deferred, thus preventing patients who are diagnosed with HTT by a definitive histopathological report from undergoing unnecessary total thyroidectomy. 55 In conclusion, if a clinically indolent tumour is suspected on the basis of radiological and cytological findings, judicious use of an indeterminate category (eg, 'FN/Suspicious for a FN'), that in The Bethesda System for Reporting Thyroid Cytopathology entails a diagnostic lobectomy, may be the most appropriate course of action.
CONCLUSION
The history of the rare hyalinizing trabecular tumour is interesting and is marked by significant controversies; to date, uncertainty still remains concerning its malignant potential and, therefore, the most appropriate moniker for it.
Although the identification of HTT on resection specimens is more straightforward, its recognition by FNA is misleading. However, careful attention and a high index of suspicion may help cytopathologists in providing a correct diagnosis and thus appropriately guide the surgeon and clinician, as HTT is virtually always benign and should be treated by a simple lobectomy.
Take home messages
▸ Cytological samples of hyalinizing trabecular tumour (HTT) show elongated cells that may be isolated, arranged in cohesive/loosely cohesive groups, or syncytial tissue fragments with a trabecular pattern; hyaline material may form central cores surrounded by neoplastic cells or may be observed in the background of the smear. ▸ Although intranuclear pseudoinclusions and nuclear grooving are frequently observed, the absence of papillary structures and fibrovascular stalks associated with the presence of a hyaline substance is an important clue to HTT diagnosis. ▸ HTT should be included in the differential diagnosis of thyroid neoplasms with discordant ultrasound (US)-cytology readings, with fine-needle aspiration suspicious for papillary thyroid carcinoma after a US without findings suggestive of malignancy. ▸ When HTT is suspected on cytological samples, judicious use of an indeterminate category leading to diagnostic lobectomy may be the most appropriate course of action on the part of the cytopathologist.
